420 related articles for article (PubMed ID: 22191529)
1. New approaches for treating staphylococcal biofilm infections.
Kiedrowski MR; Horswill AR
Ann N Y Acad Sci; 2011 Dec; 1241():104-21. PubMed ID: 22191529
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.
Schilcher K; Horswill AR
Microbiol Mol Biol Rev; 2020 Aug; 84(3):. PubMed ID: 32792334
[TBL] [Abstract][Full Text] [Related]
3. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors.
Kiran MD; Giacometti A; Cirioni O; Balaban N
Int J Artif Organs; 2008 Sep; 31(9):761-70. PubMed ID: 18924087
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
5. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
6. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of infections in humans due to Staphylococcus epidermidis.
Rupp ME
Methods Mol Biol; 2014; 1106():1-16. PubMed ID: 24222451
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of biofilm-associated antibiotic susceptibilities of methicillin-resistant staphylococci isolated from catheter-related nosocomial infections].
Bayındır Bilman F; Can F; Kaya M; Yazıcı AC
Mikrobiyol Bul; 2013 Jul; 47(3):401-16. PubMed ID: 23971919
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
11. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus.
Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR
Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721
[TBL] [Abstract][Full Text] [Related]
12. Biofilm-based implant infections in orthopaedics.
Arciola CR; Campoccia D; Ehrlich GD; Montanaro L
Adv Exp Med Biol; 2015; 830():29-46. PubMed ID: 25366219
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G
Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825
[TBL] [Abstract][Full Text] [Related]
14. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
16. A mouse model of Staphylococcus catheter-associated biofilm infection.
Heim CE; Hanke ML; Kielian T
Methods Mol Biol; 2014; 1106():183-91. PubMed ID: 24222467
[TBL] [Abstract][Full Text] [Related]
17. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity.
Hanke ML; Kielian T
Front Cell Infect Microbiol; 2012; 2():62. PubMed ID: 22919653
[TBL] [Abstract][Full Text] [Related]
18. Current and future approaches to the prevention and treatment of staphylococcal medical device-related infections.
Hogan S; Stevens NT; Humphreys H; O'Gara JP; O'Neill E
Curr Pharm Des; 2015; 21(1):100-13. PubMed ID: 25189861
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of Staphylococcus aureus biofilms.
Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibiotic efficacy against staphylococci embedded in a biofilm involved in prosthetic joint infections: A MBEC problem?
Corvec S; Aubin GG
Int J Antimicrob Agents; 2015 Jan; 45(1):90. PubMed ID: 25465522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
